Skip to main content
. 2018 Jan 1;9(3):548–555. doi: 10.7150/jca.22968

Table 4.

Number of metabolic syndrome components among control population and breast cancer patients

Number of components Stratify by age (years) Breast cancer patients (n=605)(%) Control population (n=3212)(%) p value
0 total 74(12.2%) 1246(38.8%) total: p<0.001; subgroup<60: p<0.001; subgroup≥60: p<0.001;
<60 71(11.7%) 1175(36.6%)
≥60 3(0.5%) 71(2.2%)
1 total 150(24.8%) 851(26.5%)
<60 133(22.0%) 699(21.8%)
≥60 17(2.8%) 152(4.7%)
2 total 184(30.4%) 531(16.5%)
<60 146(24.1%) 339(10.5%)
≥60 38(6.3%) 192(6.0%)
3∼5 total 197(32.6%) 584(18.2%)
<60 116(19.2%) 331(10.3%)
≥60 81(13.4%) 253(7.9%)